By JEFF GOLDSMITH There has been a lot of commentary on the largest “disrupter” candidate in healthcare, retail giant Walmart, throwing in the towel ...

By KIM BELLARD Sure, there’s lots of A.I. hype to talk about (e.g., the AI regulation proposed by Chuck Schumer, or the latest updates from ...

By PHIYEN NGUYEN Telehealth has revolutionized health care as we know it, but it may also be contributing to the overuse of antibiotics and ...

By MIKE MAGEE If you follow my weekly commentary on HealthCommentary.org or THCB, you may have noticed over the past 6 months that I appear to be ...

By KIM BELLARD Universities are having a hard time lately. They’re beset with protests the like of which we’ve not seen since the Vietnam War days, ...

By MATTHEW HOLT Given that I ran a health technology conference for many years, I tend to run in a circle of people who have some ambition to get ...

By KIM BELLARD America is crazy about gambling. Once you had to gamble illegally with a bookie, or go to Atlantic City or Las Vegas; now 45 states – ...

By MIKE MAGEE If you talk to consultants about AI in Medicine, it’s full speed ahead. GenAI assistants, “upskilling” the work force, reshaping ...

By RICHARD FRANK Demand for GLP-1 medications soared last year and shows no signs of stopping in 2024. Employers and health plans are understandably ...

By ROBBIE PEARL Soon after Apple released the original iPhone, my father, an unlikely early adopter, purchased one. His plan? “I’ll keep it in the ...

By MATTHEW HOLT A decent amount of time in recent weeks has been spent hashing out the conflict over data. Who can access it? Who can use it for ...

By KIM BELLARD When I was young, robots were Robby the Robot (Forbidden Planet, etc.), the unnamed robot in Lost in Space, or The Jetsons’ Rosey the ...